Antoine M Klauser1, Oliver T Wiebenga2, Anand Jc Eijlers3, Menno M Schoonheim3, Bernard Mj Uitdehaag4, Frederik Barkhof5, Petra Jw Pouwels6, Jeroen Jg Geurts3. 1. Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands/Department of Radiology and Medical Informatics, University of Geneva, Switzerland. 2. Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands/Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands. 3. Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands. 4. Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands. 5. Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands. 6. Department of Physics and Medical Technology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Multiple sclerosis is characterized by white matter lesions, which are visualized with conventional T2-weighted magnetic resonance imaging (MRI). Little is known about local metabolic processes preceding the appearance and during the pathological development of new lesions. OBJECTIVE: To identify metabolite changes preceding white matter (WM) lesions and pathological severity of lesions over time. METHODS: A total of 59 relapsing-remitting multiple sclerosis (MS) patients were scanned four times, with 6-month intervals. Imaging included short-TE magnetic resonance spectroscopic imaging (MRSI) and diffusion tensor imaging (DTI). RESULTS: A total of 16 new lesions appeared within the MRSI slab in 12 patients. Glutamate increased (+1.0 mM (+19%), p = 0.039) 12 and 6 months before new lesions appeared. In these areas, the increase in creatine and choline 6 months before until lesion appearance was negatively correlated with radial diffusivity (ρ = -0.73, p = 0.002 and ρ = -0.72, p = 0.002). Increase in creatine also correlated with the increase of axial diffusivity in the same period (ρ = -0.53, p = 0.034). When splitting the lesions into "mild" and "severe" based on radial diffusivity, only mild lesions showed an increase in creatine and choline during lesion formation ( p = 0.039 and p = 0.008, respectively). CONCLUSION: Increased glutamate heralded the appearance of new T2-visible WM lesions. In pathologically "mild" lesions, an increase in creatine and choline was found during lesion formation.
BACKGROUND:Multiple sclerosis is characterized by white matter lesions, which are visualized with conventional T2-weighted magnetic resonance imaging (MRI). Little is known about local metabolic processes preceding the appearance and during the pathological development of new lesions. OBJECTIVE: To identify metabolite changes preceding white matter (WM) lesions and pathological severity of lesions over time. METHODS: A total of 59 relapsing-remitting multiple sclerosis (MS) patients were scanned four times, with 6-month intervals. Imaging included short-TE magnetic resonance spectroscopic imaging (MRSI) and diffusion tensor imaging (DTI). RESULTS: A total of 16 new lesions appeared within the MRSI slab in 12 patients. Glutamate increased (+1.0 mM (+19%), p = 0.039) 12 and 6 months before new lesions appeared. In these areas, the increase in creatine and choline 6 months before until lesion appearance was negatively correlated with radial diffusivity (ρ = -0.73, p = 0.002 and ρ = -0.72, p = 0.002). Increase in creatine also correlated with the increase of axial diffusivity in the same period (ρ = -0.53, p = 0.034). When splitting the lesions into "mild" and "severe" based on radial diffusivity, only mild lesions showed an increase in creatine and choline during lesion formation ( p = 0.039 and p = 0.008, respectively). CONCLUSION: Increased glutamate heralded the appearance of new T2-visible WM lesions. In pathologically "mild" lesions, an increase in creatine and choline was found during lesion formation.
Authors: Eva Heckova; Bernhard Strasser; Gilbert J Hangel; Michal Považan; Assunta Dal-Bianco; Paulus S Rommer; Petr Bednarik; Stephan Gruber; Fritz Leutmezer; Hans Lassmann; Siegfried Trattnig; Wolfgang Bogner Journal: Invest Radiol Date: 2019-04 Impact factor: 6.016
Authors: Kirsten S Evonuk; Ryan E Doyle; Carson E Moseley; Ian M Thornell; Keith Adler; Amanda M Bingaman; Mark O Bevensee; Casey T Weaver; Booki Min; Tara M DeSilva Journal: Sci Adv Date: 2020-01-08 Impact factor: 14.136
Authors: Martin Zirngibl; Peggy Assinck; Anastasia Sizov; Andrew V Caprariello; Jason R Plemel Journal: Mol Neurodegener Date: 2022-05-07 Impact factor: 18.879
Authors: Kirsty E Waddington; Artemis Papadaki; Leda Coelewij; Marsilio Adriani; Petra Nytrova; Eva Kubala Havrdova; Anna Fogdell-Hahn; Rachel Farrell; Pierre Dönnes; Inés Pineda-Torra; Elizabeth C Jury Journal: Front Immunol Date: 2020-07-17 Impact factor: 7.561